Sathana Bunyapipat

Learn More
OBJECTIVE To evaluate the effect of depot medroxyprogesterone acetate (DMPA) in protecting against epithelial ovarian cancer (EOC) and to evaluate factors associated with the risk of EOC. DESIGN A multicentre, case-control study. SETTING Twelve hospitals located across Thailand. POPULATION Three hundred and thirty patients with EOC ('cases') and 982(More)
AIM To determine the optimal interval of injections of intramuscular depot medroxyprogesterone acetate 150 mg in the long-term treatment of endometriosis-associated pain. METHOD 112 patients with symptomatic endometriosis were randomized to receive either injections every month for 6 months, then every 3 months for a total of 15 months or injections every(More)
  • 1